KBC Group’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.05M Buy
356,759
+10,954
+3% +$71.9K 0.01% 589
2026
Q2
$1.97M Hold
345,805
– – ﹤0.01% 680
2026
Q1
$1.34M Buy
+345,805
New +$1.42M ﹤0.01% 708

Other funds holding PGEN

KBC Group's PGEN Position: Q3 2026 in Review

KBC Group increased its Precigen (PGEN) stake by 3.2% in Q3 2026, buying an estimated $71.9K and bringing the position to 356,759 shares worth $3.05M. The position accounts for 0.01% of the portfolio, ranked #589.

KBC Group first reported a position in PGEN in Q1 2026 and has held it in 3 quarters since. 191 funds tracked by Wall St. Rank hold PGEN as of Q3 2026.

  • KBC Group held 356,759 shares of Precigen worth $3.05M as of Q3 2026.
  • KBC Group bought 10,954 Precigen shares in Q3 2026, an estimated $71.9K.
  • Precigen made up 0.01% of KBC Group's portfolio in Q3 2026, its #589 holding.
  • KBC Group first reported a position in Precigen in Q1 2026 and has held it in 3 quarters since.
  • 191 funds tracked by Wall St. Rank held Precigen as of Q3 2026.

Based on KBC Group's 13F filing for Q3 2026, filed 22 Oct 2026.